Login
Register
BUSINESS/TECH
CLINICAL
REGULATORY
PROFILES
GRAND ROUNDS
EVENTS
Contact Us
Archives
Deflazacort
View Related Slideshows
FDA Approves Drug to Treat Duchenne Muscular Dystrophy
Feb 10, 2017 at 08:10 am
by
Staff
On Feb. 9, the U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dyst....
Read More
RECENT NEWS
It Has Been a Pleasure
Cognitive behavioral therapy alters brain activity in children with anxiety
Global health efforts in urology still a major focus for Joseph Smith Jr., MD
Expanded space boosts cutting-edge research in infectious diseases and immunology
TOP READS
It Has Been a Pleasure
Transforming Rare Disease Research: AI, Diversity, and Cross-Cultural Collaboration
Dr. Jimmy Kerrigan, Ascension Saint Thomas Heart, selected to be Young Leader for 2024 CRT Conference
Eli Lilly’s ‘Direct-to-Referral’ Floodgate
Clinical Trials for Weight Loss Medicine Taking Place at Midtown Clinic
News Software by Bondware